{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:13:23Z","timestamp":1783707203333,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Johnson and Johnson through Karolinska Institute","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2026,6,30]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inherited retinal diseases (IRDs) are a rare but severe cause of vision loss on a population level. This study provides a comprehensive assessment of IRD epidemiology, including incidence, prevalence and patient characteristics in Sweden over two decades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based cohort study used data from the Swedish national administrative registers including the National Patient Register. Patients with a registered diagnosis of IRD between 2006 and 2021 were identified, and age-matched and sex-matched comparators were sampled from the total population. Incidence rates and annual average prevalence stratified by age, sex and diagnostic subgroups were calculated per 100\u2009000 individuals, standardised to the 2021 Swedish population. The sociodemographic and comorbidity profile was compared between patients and comparators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 6544 IRD prevalent cases in Sweden from 2006 to 2021 and estimated a cumulative overall prevalence of 62.6\/100 000 persons. Applying a 5-year washout period (2001\u20132005), we identified 5599 newly diagnosed IRD cases between 2006 and 2021, estimating an overall average incidence rate of 3.4\/100 000 individuals\/year. Unspecified IRD accounted for over half of all prevalent cases, followed by retinitis pigmentosa-like conditions (0.6\/100 000 persons), pigment epithelial dystrophy (0.1\/100 000 persons), unspecified hereditary retinal dystrophy (0.1\/100 000 persons), other hereditary retinal dystrophy and vitreoretinal dystrophy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This nationwide population-based study provides the first comprehensive estimates of IRD prevalence and incidence in Sweden. The findings indicate a stable incidence of IRD over the past two decades. These results underscore the need for ongoing surveillance and targeted healthcare planning to address the evolving burden of IRDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2026-329787","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:20:28Z","timestamp":1783704028000},"page":"bjo-2026-329787","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Nationwide incidence and prevalence of inherited retinal disease in Sweden, 2006\u20132021: a population-based register study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3901-5384","authenticated-orcid":false,"given":"Muwada Bashir Awad","family":"Bashir","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wennberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"H\u00e4bel","sequence":"additional","affiliation":[{"name":"Department of Learning, Informatics, Management and Ethics, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Chizarifard","sequence":"additional","affiliation":[{"name":"Department of Learning, Informatics, Management and Ethics, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Linder","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[{"name":"Global Commercial Strategy Organization, Janssen-Cilag AB, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Global Commercial Strategy Organization (GCSO), Johnson & Johnson Innovative Medicine, Raritan, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi","family":"Ogundele","sequence":"additional","affiliation":[{"name":"Global Commercial Strategy Organization (GCSO), Johnson & Johnson Innovative Medicine, Raritan, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Intervention and Technology, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"L\u00f6fgren","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden"},{"name":"St Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026071010202194000_bjo-2026-329787v1.1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.7.4.6","article-title":"Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps","volume":"7","author":"Duncan","year":"2018","journal-title":"Trans Vis Sci Tech"},{"key":"2026071010202194000_bjo-2026-329787v1.2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041277","article-title":"Comparison of Worldwide Disease Prevalence and Genetic Prevalence of Inherited Retinal Diseases and Variant Interpretation Considerations","volume":"14","author":"Hanany","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026071010202194000_bjo-2026-329787v1.3","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_91"},{"key":"2026071010202194000_bjo-2026-329787v1.4","doi-asserted-by":"publisher","DOI":"10.1111\/AOS.14218"},{"key":"2026071010202194000_bjo-2026-329787v1.5","article-title":"Next-Generation Sequencing: The Translational Medicine Approach from \u201cBench to Bedside to Population\u201d","volume":"3","author":"Beigh","year":"2016","journal-title":"Medicines (Basel)"},{"key":"2026071010202194000_bjo-2026-329787v1.6","doi-asserted-by":"crossref","DOI":"10.1038\/srep33248","article-title":"Panel-Based Population Next-Generation Sequencing for Inherited Retinal Degenerations","volume":"6","author":"Carrigan","year":"2016","journal-title":"Sci Rep"},{"key":"2026071010202194000_bjo-2026-329787v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.12.003"},{"key":"2026071010202194000_bjo-2026-329787v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.009"},{"key":"2026071010202194000_bjo-2026-329787v1.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24636-1","article-title":"Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy","volume":"12","author":"Karali","year":"2022","journal-title":"Sci Rep"},{"key":"2026071010202194000_bjo-2026-329787v1.10","doi-asserted-by":"publisher","DOI":"10.1002\/HUMU.23903"},{"key":"2026071010202194000_bjo-2026-329787v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9350-y"},{"key":"2026071010202194000_bjo-2026-329787v1.12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1403494817702327","article-title":"Estimating incidence and prevalence from population registers: example from myocardial infarction","volume":"45","author":"Modig","year":"2017","journal-title":"Scand J Public Health"},{"key":"2026071010202194000_bjo-2026-329787v1.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-025-01221-0"},{"key":"2026071010202194000_bjo-2026-329787v1.14","unstructured":"Socialstyrelsen . Production and quality of the statistical register \u2013 register of round-the-clock interventions for children and young people, 2021-12-7710. 2021. Available: https:\/\/www.socialstyrelsen.se\/publikationer\/det-statistiska-registrets-framstallning-och-kvalitet--registret-over-heldygnsinsatser-till-barn-och-unga-2021-12-7710\/"},{"key":"2026071010202194000_bjo-2026-329787v1.15","unstructured":"Welfare TNBoHa . National patient register. 2025."},{"key":"2026071010202194000_bjo-2026-329787v1.16","unstructured":"Socialstyrelsen . NPR det statistiska registrets framst\u00e4llning och kvalitet, 2022\u20112\u20117767. 2022. Available: https:\/\/www.socialstyrelsen.se\/contentassets\/6658c625622145abb93680eb1ee090f8\/2022-2-7767.pdf"},{"key":"2026071010202194000_bjo-2026-329787v1.17","unstructured":"The National Board of Health and Welfare . National prescribed drug register. n.d. Available: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-prescribed-drug-register\/"},{"key":"2026071010202194000_bjo-2026-329787v1.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0117-y"},{"key":"2026071010202194000_bjo-2026-329787v1.19","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0316-1"},{"key":"2026071010202194000_bjo-2026-329787v1.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00511-8"},{"key":"2026071010202194000_bjo-2026-329787v1.21","unstructured":"Socialstyrelsen . Det statistiska registrets framst\u00e4llning och kvalitet \u2013 registret \u00f6ver socialtj\u00e4nstinsatser till \u00e4ldre och personer med funktionsneds\u00e4ttning, 2023-1-8341. 2023. Available: https:\/\/www.socialstyrelsen.se\/publikationer\/det-statistiska-registrets-framstallning-och-kvalitet--registret-over-socialtjanstinsatser-till-aldre-och-personer-med-funktionsnedsattning-2023-1-8341\/"},{"key":"2026071010202194000_bjo-2026-329787v1.22","unstructured":"SKR (Sveriges kommuner och regioner) . Nationellt programomr\u00e5de \u00f6gonsjukdomar \u2014 kunskapsstyrning v\u00e5rd. n.d. Available: https:\/\/kunskapsstyrningvard.se\/kunskapsstyrningvard\/programomradenochsamverkansgrupper\/nationellaprogramomraden\/npoogonsjukdomar.56468.html"},{"key":"2026071010202194000_bjo-2026-329787v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2026071010202194000_bjo-2026-329787v1.24","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S90589"},{"key":"2026071010202194000_bjo-2026-329787v1.25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/cer.14.53","article-title":"Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient","volume":"4","author":"Roberts","year":"2015","journal-title":"J Comp Eff Res"},{"key":"2026071010202194000_bjo-2026-329787v1.26","unstructured":"Breslow N , Day N . Volume II-the design and analysis of cohort studies. Lyon International Agency for Research on Cancer; 1987. 273\u20139."},{"key":"2026071010202194000_bjo-2026-329787v1.27","unstructured":"Statistics Sweden . Sweden\u2019s population in summary 1960-2024. n.d. Available: https:\/\/www.scb.se\/en\/finding-statistics\/statistics-by-subject-area\/population-and-living-conditions\/population-composition-and-development\/population-statistics\/pong\/tables-and-graphs\/population-statistics---summary\/swedens-population-in-summary-1960-2024\/"},{"key":"2026071010202194000_bjo-2026-329787v1.28","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02798-z","article-title":"A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice","volume":"18","author":"Murro","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026071010202194000_bjo-2026-329787v1.29","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2025-327427"},{"key":"2026071010202194000_bjo-2026-329787v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2025.07.021"},{"key":"2026071010202194000_bjo-2026-329787v1.31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4419-1399-9_29","article-title":"Mutation spectra in autosomal dominant and recessive retinitis pigmentosa in northern Sweden","volume":"664","author":"Golovleva","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"2026071010202194000_bjo-2026-329787v1.32","first-page":"618","article-title":"Clinical Characterization and Frequency of Observation of Hereditary Retinal Diseases: Multicentric Study in Panama in 2012-2013","volume":"4","author":"Cu\u00e9llar","year":"2016","journal-title":"J Pharm Pharmacol"},{"key":"2026071010202194000_bjo-2026-329787v1.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054111","article-title":"Prevalence and associated relating factors in patients with hereditary retinal dystrophy: a nationwide population-based study in Taiwan","volume":"12","author":"Woon","year":"2022","journal-title":"BMJ Open"},{"key":"2026071010202194000_bjo-2026-329787v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/gbx162"},{"key":"2026071010202194000_bjo-2026-329787v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.005"},{"key":"2026071010202194000_bjo-2026-329787v1.36","first-page":"5300","article-title":"Significant reduction in time to clinical diagnosis and genetic testing for inherited retinal disease patients in the past five years","volume":"65","author":"Wagner","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026071010202194000_bjo-2026-329787v1.37","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2147\/CLEP.S178955","article-title":"Thirty-year trends in dementia: a nationwide population study of Swedish inpatient records","volume":"10","author":"Seblova","year":"2018","journal-title":"Clin Epidemiol"},{"key":"2026071010202194000_bjo-2026-329787v1.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307266","article-title":"Avidity sequencing of whole genomes from retinal degeneration pedigrees identifies causal variants","volume":"19","author":"Biswas","year":"2024","journal-title":"PLoS One"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2026-329787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:20:31Z","timestamp":1783704031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2026-329787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":38,"alternative-id":["10.1136\/bjo-2026-329787"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2026-329787","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}